SonarMed

About:

SonarMed develops technology to improve the placement and monitoring of endotracheal tubes used in patients who cannot breathe on their own.

Website: http://www.sonarmed.com

Top Investors: BioCrossroads, HPA (Hyde Park Angels), VisionTech Partners, Central Texas Angel Network, Baylor Angel Network

Description:

SonarMed was founded in 2005 to commercialize technology licensed from Purdue University to improve the placement and monitoring of endotracheal (breathing) tubes (also known as ETTs or artificial airways) which are used in patients who cannot breathe on their own. The technology was initially developed at Purdue University by SonarMed founders Jeffrey Mans-field, Eduardo Juan and George Wodicka, using the principles of acoustic reflectometry in tubes to provide the medical community with a more comprehensive approach to assist in the maintenance of breathing tubes.

Total Funding Amount:

$12.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Indianapolis, Indiana, United States

Founded Date:

2005-01-01

Contact Email:

sales(AT)sonarmed.com

Founders:

Jeff Mansfield

Number of Employees:

11-50

Last Funding Date:

2017-10-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai